| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/SREP38962 |
| P8608 | Fatcat ID | release_r3uhyzoctrh4nazblrblzylbii |
| P932 | PMC publication ID | 5154179 |
| P698 | PubMed publication ID | 27958342 |
| P2093 | author name string | Lu Wang | |
| Cong Wang | |||
| Yufeng Cheng | |||
| Xiaochen Huang | |||
| Jiangfeng Wang | |||
| P2860 | cites work | 7th Edition of the AJCC Cancer Staging Manual: Esophagus and Esophagogastric Junction | Q63546492 |
| Vitamin D | Q78117743 | ||
| Staging of esophageal carcinoma: length of tumor and number of involved regional lymph nodes. Are these independent prognostic factors? | Q80246354 | ||
| Global cancer statistics | Q22241238 | ||
| Vitamin D stimulates apoptosis in gastric cancer cells in synergy with trichostatin A /sodium butyrate-induced and 5-aza-2'-deoxycytidine-induced PTEN upregulation | Q24296637 | ||
| Vitamin D and Colorectal, Breast, and Prostate Cancers: A Review of the Epidemiological Evidence | Q26766256 | ||
| Protective links between vitamin D, inflammatory bowel disease and colon cancer | Q26774600 | ||
| Global cancer statistics, 2012 | Q27860501 | ||
| Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 | Q27860674 | ||
| The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology | Q29615701 | ||
| Products of vitamin D3 or 7-dehydrocholesterol metabolism by cytochrome P450scc show anti-leukemia effects, having low or absent calcemic activity. | Q33548669 | ||
| Vitamin d binding protein and bone health | Q33759023 | ||
| Vitamin D: considerations in the continued development as an agent for cancer prevention and therapy | Q33802601 | ||
| Meta-analysis: serum vitamin D and breast cancer risk | Q34114474 | ||
| Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma | Q34115732 | ||
| Mechanisms of the Anti-Cancer and Anti-Inflammatory Actions of Vitamin D | Q34142846 | ||
| Vitamin D and cancer: a review of molecular mechanisms | Q34240570 | ||
| The role of vitamin D in reducing cancer risk and progression | Q34413846 | ||
| 20-Hydroxyvitamin D2 is a noncalcemic analog of vitamin D with potent antiproliferative and prodifferentiation activities in normal and malignant cells | Q34717974 | ||
| 1,25-Dihydroxyvitamin D3 induces monocytic differentiation of human myeloid leukemia cells by regulating C/EBPβ expression through MEF2C | Q35181504 | ||
| Low Serum Vitamin D Levels Are Associated With Inferior Survival in Follicular Lymphoma: A Prospective Evaluation in SWOG and LYSA Studies | Q35501693 | ||
| The effect of pre-diagnostic vitamin D supplementation on cancer survival in women: a cohort study within the UK Clinical Practice Research Datalink | Q35803741 | ||
| Detection of novel CYP11A1-derived secosteroids in the human epidermis and serum and pig adrenal gland. | Q36134223 | ||
| In vivo evidence for a novel pathway of vitamin D₃ metabolism initiated by P450scc and modified by CYP27B1. | Q36183704 | ||
| Recreational physical activity, body mass index, and survival in women with colorectal cancer | Q36403558 | ||
| A pooled analysis of post-diagnosis lifestyle factors in association with late estrogen-receptor-positive breast cancer prognosis | Q36609722 | ||
| Impact of very low physical activity, BMI, and comorbidities on mortality among breast cancer survivors | Q36899847 | ||
| Circulating 25-Hydroxyvitamin D and Prostate Cancer Survival | Q36917872 | ||
| Vitamin D signalling pathways in cancer: potential for anticancer therapeutics | Q36919979 | ||
| In vivo production of novel vitamin D2 hydroxy-derivatives by human placentas, epidermal keratinocytes, Caco-2 colon cells and the adrenal gland. | Q37719172 | ||
| Hepatocellular carcinoma and vitamin D: a review | Q37924314 | ||
| Nutrition and physical activity guidelines for cancer survivors | Q38005959 | ||
| Vitamin D and breast cancer: emerging concepts | Q38059023 | ||
| Antineoplastic effects of 1,25(OH)2D3 and its analogs in breast, prostate and colorectal cancer | Q38074136 | ||
| Improved clinical outcomes associated with vitamin D supplementation during adjuvant chemotherapy in patients with HER2+ nonmetastatic breast cancer | Q38252914 | ||
| Practical clinical interventions for diet, physical activity, and weight control in cancer survivors | Q38356424 | ||
| Vitamin D and pancreas: The role of sunshine vitamin in the pathogenesis of diabetes mellitus and pancreatic cancer | Q38794281 | ||
| Antiproliferative Activity of Double Point Modified Analogs of 1,25-Dihydroxyvitamin D₂ Against Human Malignant Melanoma Cell Lines. | Q38804186 | ||
| 1α,25-Dihydroxyvitamin D₃ inhibits the human H295R cell proliferation by cell cycle arrest: a model for a protective role of vitamin D receptor against adrenocortical cancer | Q39056849 | ||
| Vitamin D supplementation and quality of life following diagnosis in stage II colorectal cancer patients: a 24-month prospective study | Q40499279 | ||
| A prospective study of plasma 25-hydroxyvitamin D concentration and prostate cancer risk | Q41122869 | ||
| Meta-analysis of vitamin D sufficiency for improving survival of patients with breast cancer | Q44288856 | ||
| Vitamin D is associated with improved survival in early-stage non-small cell lung cancer patients | Q45298729 | ||
| Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer | Q47805138 | ||
| Vitamin D deficiency and its association with fatigue and quality of life in advanced cancer patients under palliative care: A cross-sectional study | Q47977959 | ||
| MART-10, the new brand of 1α,25(OH)2D3 analog, is a potent anti-angiogenic agent in vivo and in vitro. | Q48074479 | ||
| Vitamin D deficiency in patients with inflammatory bowel disease: association with disease activity and quality of life | Q48683216 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | vitamin | Q34956 |
| esophageal cancer | Q372701 | ||
| vitamin D | Q175621 | ||
| P304 | page(s) | 38962 | |
| P577 | publication date | 2016-12-13 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Longitudinal, observational study on associations between postoperative nutritional vitamin D supplementation and clinical outcomes in esophageal cancer patients undergoing esophagectomy | |
| P478 | volume | 6 |
| Q38622264 | Dietary Supplements Commonly Used by Cancer Survivors: Are There Any Benefits? |
| Q89690246 | Exercise and cancer: a position statement from the Spanish Society of Medical Oncology |
| Q58133485 | Influence of vitamin D on cancer risk and treatment: Why the variability? |
| Q39275274 | Integrative medicine in cancer survivors |
| Q47283213 | Validation of EORTC QLQ-OES18 for Chinese patients with esophageal cancer |
| Q90235430 | Vitamin D and Gastrointestinal Cancers: A Narrative Review |
| Q57821057 | Vitamin D receptor as a marker of prognosis in oesophageal adenocarcinoma: a prospective cohort study |
Search more.